Robert J. Pariser

1.6k total citations
44 papers, 934 citations indexed

About

Robert J. Pariser is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Robert J. Pariser has authored 44 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Dermatology, 14 papers in Epidemiology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Robert J. Pariser's work include Autoimmune Bullous Skin Diseases (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Contact Dermatitis and Allergies (4 papers). Robert J. Pariser is often cited by papers focused on Autoimmune Bullous Skin Diseases (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Contact Dermatitis and Allergies (4 papers). Robert J. Pariser collaborates with scholars based in United States. Robert J. Pariser's co-authors include David M. Pariser, Daniel Stewart, Paul S. Yamauchi, Nicholas J. Lowe, Michael Jarratt, Anne W. Lucky, J. Richard Taylor, Paul R. Bergstresser, Stefanie A. Hirano and Molly K. Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Journal of Investigative Dermatology.

In The Last Decade

Robert J. Pariser

40 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Pariser United States 18 421 350 226 141 120 44 934
Heng‐Leong Chan Taiwan 20 194 0.5× 499 1.4× 95 0.4× 257 1.8× 110 0.9× 41 1.3k
M.R.C. Path United Kingdom 14 175 0.4× 138 0.4× 207 0.9× 143 1.0× 43 0.4× 30 956
S. A. Muller United States 16 131 0.3× 189 0.5× 84 0.4× 82 0.6× 122 1.0× 30 745
Zekayі Kutlubay Türkiye 18 177 0.4× 479 1.4× 70 0.3× 74 0.5× 82 0.7× 116 1.0k
E. G. Jung Germany 18 324 0.8× 350 1.0× 233 1.0× 280 2.0× 66 0.6× 68 1.4k
K. Keczkes United Kingdom 16 299 0.7× 407 1.2× 53 0.2× 86 0.6× 43 0.4× 38 783
J Bazex France 17 234 0.6× 567 1.6× 49 0.2× 106 0.8× 87 0.7× 126 1.1k
R S Barnetson Australia 15 317 0.8× 414 1.2× 89 0.4× 214 1.5× 37 0.3× 23 1.2k
Moon‐Bum Kim South Korea 18 271 0.6× 544 1.6× 43 0.2× 110 0.8× 111 0.9× 112 1.0k
Husein Husein‐ElAhmed Spain 16 250 0.6× 388 1.1× 48 0.2× 150 1.1× 42 0.3× 96 763

Countries citing papers authored by Robert J. Pariser

Since Specialization
Citations

This map shows the geographic impact of Robert J. Pariser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Pariser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Pariser more than expected).

Fields of papers citing papers by Robert J. Pariser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Pariser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Pariser. The network helps show where Robert J. Pariser may publish in the future.

Co-authorship network of co-authors of Robert J. Pariser

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Pariser. A scholar is included among the top collaborators of Robert J. Pariser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Pariser. Robert J. Pariser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borda, Luis J., et al.. (2024). Late subsequent Merkel cell carcinoma after 21 years of the first primary diagnosis: When to de‐escalate surveillance?. SHILAP Revista de lepidopterología. 12(8). e9340–e9340. 2 indexed citations
2.
Borda, Luis J., et al.. (2024). Diagnostic Accuracy of Treponema pallidum Immunostaining in a Cohort of Patients With Secondary Syphilis. Journal of Cutaneous Pathology. 52(5). 333–335.
4.
Brown, Isabelle & Robert J. Pariser. (2024). Generalized Hailey-Hailey disease associated with c.2395C>T ATP2C1 gene mutation and fatal outcome.. Dermatology Online Journal. 30(2).
5.
Reznik, Alex, et al.. (2024). YouTube as a source of information for self-skin examinations: an analysis of content and quality. Clinical and Experimental Dermatology. 49(11). 1436–1437. 1 indexed citations
6.
Pariser, Robert J., et al.. (2023). Optic neuropathy in a patient treated with adalimumab for hidradenitis suppurativa. JAAD Case Reports. 37. 85–88.
7.
Borda, Luis J., et al.. (2023). Grouped follicular secondary syphilis: Case report and review of literature. Australasian Journal of Dermatology. 64(2). e168–e170. 3 indexed citations
8.
Borda, Luis J., et al.. (2022). Sebaceous “adenoma” of an arm recurring as a carcinoma: The value of DNA mismatch repair gene expression immunohistochemistry. JAAD Case Reports. 30. 44–47. 2 indexed citations
9.
Pariser, Robert J., et al.. (2021). Unilateral Distribution of Lichen Planus Pigmentosus-Inversus Unresponsive to Clobetasol and Hydroquinone. Cureus. 13(8). e17368–e17368. 1 indexed citations
10.
Pariser, Robert J., et al.. (2021). Epidermolysis bullosa pruriginosa responding to dupilumab. JAAD Case Reports. 16. 69–71. 18 indexed citations
11.
Pariser, Robert J., et al.. (2012). A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. Journal of the American Academy of Dermatology. 68(5). 765–773. 92 indexed citations
13.
Pariser, David M., Nicholas J. Lowe, Daniel Stewart, et al.. (2003). Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial. Journal of the American Academy of Dermatology. 48(2). 227–232. 221 indexed citations
14.
Pariser, Robert J., et al.. (2003). Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death. Journal of the American Academy of Dermatology. 49(5). 262–264. 6 indexed citations
15.
Pariser, Robert J., et al.. (1999). The relationship between biopsy technique and uncertainty in the histopathologic diagnosis of melanoma. Dermatology Online Journal. 5(2). 4–4. 23 indexed citations
16.
Pariser, Robert J.. (1998). BENIGN NEOPLASMS OF THE SKIN. Medical Clinics of North America. 82(6). 1285–1307. 22 indexed citations
17.
Lange, David G., Joseph A. Guarnieri, R Savin, et al.. (1998). Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 39(6). 944–950. 32 indexed citations
18.
Pariser, Robert J.. (1994). “Nevocentric” erythema multiforme. Journal of the American Academy of Dermatology. 31(3). 491–492. 7 indexed citations
19.
Pariser, Robert J., et al.. (1994). Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. Journal of the American Academy of Dermatology. 31(2). 232–234. 17 indexed citations
20.
Pariser, Robert J.. (1983). Histologically specific skin lesions in disseminated cytomegalovirus infection. Journal of the American Academy of Dermatology. 9(6). 937–946. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026